Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

NCT03470233 · clinicaltrials.gov ↗

COMPLETED

Status

149

Enrollment

INDUSTRY

Sponsor class

Conditions

Multi-drug Resistant Tuberculosis

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.